Astrocytoma, isocitrate dehydrogenase-mutant, WHO grade 4 (Astro4), is a new tumor type in the 2021 WHO classification of central nervous system tumors that has been poorly characterized in the literature.
This study evaluates predictors of prognosis in a large cohort of newly diagnosed Astro4.
